NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

Name

Capella university

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation:

Introduction

Good morning, and welcome to today’s session on Human Papillomavirus (HPV) prevention. We are pleased to see our partners gathered here to address a crucial public health concern impacting adolescents and young adults between the ages of 11 and 26 in Schwenksville, Pennsylvania. This presentation is designed to increase awareness of HPV, emphasize its connection to various cancers, highlight the benefits of timely vaccination, and provide practical strategies for communicating with healthcare professionals and families about the HPV vaccine. This session is structured around pre-developed SMART goals and aligns with the objectives of Healthy People 2030.

Presentation Roadmap

The flow of this session is intended to offer participants vital insights and actionable knowledge. The agenda includes the following:

  1. Sharing key facts about HPV, including its transmission and carcinogenic potential.
  2. Describing the safety, effectiveness, and significance of timely HPV vaccination.
  3. Encouraging participants to schedule the HPV vaccine within 30 days.
  4. Enhancing communication confidence with healthcare providers and family members.
  5. Engaging attendees in interactive learning and discussion activities.
  6. Evaluating knowledge and confidence levels through a post-session quiz and survey.

Key Concepts and Supporting Evidence

Topic Summary Supporting Sources
HPV and Cancer HPV is a prevalent virus spread through skin-to-skin and sexual contact, contributing to cancers such as cervical, throat, and genital cancers. In Pennsylvania, rural areas like Schwenksville have significantly lower HPV vaccination rates and higher cancer incidences (PA.gov, 2025). Huber et al., 2021; PA.gov, 2025
Benefits of Vaccination Administering the vaccine before HPV exposure—preferably around ages 11–12—provides strong immune protection and helps prevent several cancers and genital warts. Immunizing adolescents decreases individual risk and contributes to community-wide herd immunity. Hoes et al., 2021; Cheng et al., 2020; Xu et al., 2024
Communication Strategies To promote HPV vaccination, individuals should use evidence-based information, ask informed questions, and debunk myths. Addressing misconceptions, such as linking the vaccine to sexual behavior, is key to informed decision-making. Kassymbekova et al., 2023; CDC, WHO

SMART Goals and Evaluation

SMART Goals

The following SMART goals were established to evaluate the effectiveness of this health promotion session:

  1. Knowledge Acquisition: At least 90% of participants will identify three key facts about HPV and its association with cancer by the end of the session.
  2. Vaccine Commitment: At least 80% of participants will commit to scheduling the HPV vaccine within 30 days.
  3. Communication Confidence: At least 85% of participants will report improved confidence in discussing HPV vaccination with others.

These goals were intended to promote learning and empowerment, enabling participants to advocate for their health and their community’s well-being.

SMART Goal Evaluation

The session demonstrated mixed results in goal achievement:

  • Goal 1 was met, with 92.5% of participants accurately identifying HPV-related cancer facts.
  • Goal 2 was slightly unmet, as only 75% of participants committed to initiating vaccination within 30 days.
  • Goal 3 was met, with 85% expressing greater confidence in discussing HPV vaccination.

Some challenges emerged during evaluation. Teen participants often hesitated to commit without family consultation. Additionally, a few attendees reported feeling unprepared to counter common myths effectively. To address these issues, future sessions should incorporate earlier opportunities for family engagement, enhanced role-playing exercises, and possible follow-up meetings to support decision-making and reinforce accurate information.

Alignment with Healthy People 2030 Objectives

This session supports Healthy People 2030’s objectives, particularly in increasing adolescent HPV vaccination rates and reducing HPV-related cancer incidence. By boosting participants’ knowledge and communication readiness, the program made meaningful strides toward national health targets. However, the goal of immediate vaccine initiation fell short. This gap reveals the need for deeper engagement strategies, including more robust myth-busting components and enhanced family-oriented discussions. These improvements can foster stronger trust and increase vaccination uptake.

Conclusion

In summary, the health education session successfully increased awareness and understanding of HPV and its risks among adolescents and young adults in Schwenksville, PA. While most participants demonstrated enhanced knowledge and confidence, further efforts are needed to raise commitment levels for immediate vaccination. The use of SMART goals and alignment with Healthy People 2030 provided a structured, evidence-based framework to guide the intervention. Moving forward, incorporating more interactive elements, extended family engagement, and follow-up sessions will bolster future success in HPV prevention and public health outcomes.

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17, 174550652110207. https://doi.org/10.1177/17455065211020702

Kassymbekova, F., Zhetpisbayeva, I., Tcoy, E., Dyussenov, R., Davletov, K., Rommel, A., & Glushkova, N. (2023). Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: A mixed-methods study protocol. BMJ Open, 13(9), e074097. https://doi.org/10.1136/bmjopen-2023-074097

NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

PA.gov. (2025). Dear VFC provider. https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/immunizations/3.3.25%20-%202025%20HPV%20Call-to-Action%20Letter%20and%20Resources.pdf

U.S. Department of Health and Human Services. (n.d.). Vaccination – Healthy People 2030. Health.govhttps://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination

Xu, M., Choi, J., Capasso, A., & DiClemente, R. (2024). Improving HPV vaccination uptake among adolescents in low-resource settings: Sociocultural and socioeconomic barriers and facilitators. Adolescent Health Medicine and Therapeutics, 15, 73–82. https://doi.org/10.2147/ahmt.s394119

NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation